General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
FTC Warns ‘Junk Patents' Could Make Drugs Like Ozempic Pricier—Here's How | forbes.com • |
Novo, Teva, AstraZeneca issued FTC warnings over 'bogus' patents (NYSE:TEVA) | news.google.com • |
GSK: 3 Top Pharma Stocks for May 2024 | news.google.com • |
abrdn plc Grows Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) | news.google.com • |
You Would Fire “God” As Your Portfolio Manager | investorplace.com • |
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects | zacks.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-08 | 2024-03 | 0.51 | N/A | N/A | N/A |
2024-01-31 | 2023-12 | 0.75 | 1 | 0.25 | 33.33% |
2023-11-08 | 2023-09 | 0.6 | 0.6 | N/A | N/A |
2023-08-02 | 2023-06 | 0.54 | 0.56 | 0.02 | 3.70% |
2023-05-10 | 2023-03 | 0.57 | 0.4 | -0.17 | -29.82% |
2023-02-08 | 2022-12 | 0.68 | 0.71 | 0.03 | 4.41% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-19 | UBS | Upgrade | Neutral | Neutral |
2023-09-07 | B of A Securities | Upgrade | Buy | Buy |
2023-07-05 | UBS | Upgrade | Sell | Neutral |
2023-05-24 | Morgan Stanley | Upgrade | Equal-Weight | |
2023-05-17 | Evercore ISI Group | Upgrade | In-Line | Outperform |
2023-05-10 | B of A Securities | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-27 | BERGWERK DOV | Officer | 96.98K | Conversion of Exercise of derivative security |
2024-03-03 | DRAPE ERIC | Officer | 77.93K | Conversion of Exercise of derivative security |
2024-03-03 | FRANCIS RICHARD D | Chief Executive Officer | 123.30K | Sale |
2024-03-03 | KALIF ELIYAHU SHARON | Chief Financial Officer | 207.53K | Conversion of Exercise of derivative security |
2024-03-04 | SABAG MARK | Officer | 382.59K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 40.29M | 303.38M | 3.59% |
2023-06-29 | Phoenix Holdings Ltd. | 33.70M | 253.79M | 3.01% |
2023-06-29 | Ion Asset Management Limited | 33.06M | 248.96M | 2.95% |
2023-06-29 | Clal Insurance Enterprises Holdings Ltd | 31.61M | 238.06M | 2.82% |
2023-06-29 | Menora Mivtachim Holdings Ltd. | 26.58M | 200.14M | 2.37% |
2023-06-29 | Lingotto Investment Management Llp | 24.21M | 182.33M | 2.16% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Fundamental Investors Inc | 6.73M | 68.62M | 0.60% |
2023-08-30 | iShares Core MSCI EAFE ETF | 6.19M | 60.43M | 0.55% |
2023-09-29 | iShares MSCI Eafe ETF | 3.52M | 35.90M | 0.31% |
2023-07-30 | New World Fund, Inc. | 2.98M | 25.03M | 0.27% |
2023-05-30 | Fidelity International Index Fund | 2.91M | 20.94M | 0.26% |
2023-09-29 | iShares MSCI Eafe Value ETF | 2.51M | 25.56M | 0.22% |
Dividend | Date |
---|---|
0.085 | 2017-11-27 |
0.085 | 2017-08-25 |
0.34 | 2017-06-01 |
0.34 | 2017-02-28 |
0.34 | 2016-12-01 |
0.34 | 2016-08-18 |
Split | Date |
---|---|
2 : 1 | 2004-07-01 |
2 : 1 | 2002-12-06 |
2 : 1 | 2000-02-23 |
2 : 1 | 1993-04-14 |
1 : 1 | 1982-08-16 |
$TEVA very well said M. Thank you for being humble about it
The deal with Sanofi is $1.5 for 60% then Teva got $1.5 plus the value for the other 50% at least $1.5…
$3B only from this drug…
9, 12 , 15 ——> 24
Earning $9.5
$8 end of the day
To the moon
to the moon
towards 9
#Brilliant with all that boxing in of settlements. Given the inflationary outlook for years to come, the debt and settlement liabilities will diminish significantly compared to future pricing development when discounted in todays value
$TEVA. Is it true that Buffet got rid of all his shares?
Net debt down $2.8B and FCF is $2.2B maybe the balance is the 0.5B redemption of convertible bonds.
1-2 months of Patience equals to $11-12
6 months of Patience equals to $14-18
Year or two of Patience equals to $22-25
TEVA settled global litigation, news just out
Above 10 today
️️️️
To the moon